Last reviewed · How we verify
NCT05748808: BReTIA
Use of Biofeedback and Virtual Reality as Facilitators of Emotional Recognition in the Treatment of Aggressive Outbursts
NA trial testing Use of biofeedback and virtual reality in the treatment of aggressive outbursts in Passive-Aggressive Personality Disorder in 60 participants. Currently enrolling.
1 February 2025
Quick facts
| Lead sponsor | University of Seville |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 September 2024 |
| Primary completion | 1 February 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Use of biofeedback and virtual reality in the treatment of aggressive outbursts
Conditions studied
- Passive-Aggressive Personality Disorder — all drugs for Passive-Aggressive Personality Disorder →
Sponsor
University of Seville
Who can join
Adults 10 to 16, any sex, with Passive-Aggressive Personality Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The methodology will be applied for the treatment of aggressive episodes. Many people show this kind of behavior associated with several psychological disorders like austistic spectrum disorder (ASD). It will be studied the effect of aggressive outbursts on several physiological signals (heart rate (HR), breathing rate (BR), electroencephalography (EEG), etc). The use of those signals in a biofeedback loop could help patients recognize their internal states and avoid imminent aggression. The study want to verify the efficacy of a cognitive therapy that includes biofeedback and virtual reality (VR) and find out the most significant physiological features that are affected by these episodes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05748808
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Seville trials
Trials by the same sponsor.
- NCT07501273 — Analgesic Effect of a Biophotonic Foot Massage Cream · NA · not yet recruiting
- NCT07387627 — Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders · NA · not yet recruiting
- NCT07361887 — Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. · NA · recruiting
- NCT06978582 — Effectiveness and Safety of a Tele-Rehabilitation Program on Fatigue and Related Variables in Chronic Fatigue Syndrome a · NA · active not recruiting
- NCT07208045 — Cultural Adaptation, Validation, and Evaluation of the Programme for Promotion of Healthy Affective-Sexual Behaviours in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05748808 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Seville
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748808.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing